Ceribell CEO sells $841,292 in company stock

Chao Xingjuan, CEO of Ceribell, sold $841,292 worth of company stock in August 2026, according to reports. The transactions, conducted under a Rule 10b5-1 trading plan, took place over two days, with shares exchanged at prices between $25.00 and $25.03 each. The sale occurred in two installments: 2,199 shares on August 18 at $25.00, followed by 31,415 shares on August 19 at a weighted average price of $25.03.

These shares were among Ceribell's most valuable, with the stock reaching a 52-week high of $25.33. The sale came as Ceribell reported a 33% increase in revenue to $28.1 million in Q2 of fiscal 2026, despite a loss of $0.51 per share. Despite this, the company's growth in seizure-detection technology and new products for delirium monitoring and pediatric care has attracted investor interest.

This surge in stock value has led analysts to raise their price targets for Ceribell shares. Currently held by Ms. Chao herself and by the ACP 2021 Trust, of which she is a co-trustee, these shares represent a significant stake in the company.